ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulligan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulligan, R.
Annals of Clinical and Laboratory Science, Vol 5, Issue 2, 82-90
Copyright © 1975 by Association of Clinical Scientists


Articles

Etiologic factors in carcinoma of the prostate

RM Mulligan

A staining method is presented by which azocarmine combines with spermine to form a poorly soluble red precipitate highlighted against the yellow cytoplasm of positive cells achieved by counterstaining with metanil yellow. In the prostate, the spermine-dye complex was abundant in normal acinar epithelial cells, moderate in the epithelial cells of hyperplastic glands, and moderate to absent in carcinoma cells. Spermine is evidently concerned with stabilizing the structure of desoxyribose nucleic acid and probably of proteins, notably several zinc metalloenzymes. Diagnosis and treatment of carcinoma of the prostate should include an adequate basic diet, retention of testes, hormonal treatment oriented toward testicular, pituitary and hypothalamic hormones; zinc--ordinary and radioactive; and utilization of spermine and precursors.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the Association of Clinical Scientists.